COMMUNIQUÉS West-GlobeNewswire

Algae Biomass Organization Bringing 2019 Algae Biomass Summit to Orlando, Florida
13/12/2018
Largest algae conference in the world now accepting abstracts and proposals for advances in algae for food and feed, biofuels and biomaterials, water, air and soil ORLANDO, Fla., Dec. 13, 2018 (GLOBE NEWSWIRE) -- The [...]
Diffusion Pharmaceuticals Announces 1-for-15 Reverse Stock Split As Part Of NASDAQ Compliance Plan
13/12/2018
CHARLOTTESVILLE, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) , a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving [...]
Retrotope Announces First Dosing of RT001 in patients with Infantile Neuroaxonal Dystrophy (INAD)
13/12/2018
Two participating clinical trials centers now open for enrollment LOS ALTOS, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today that it has begun enrollment of the first patients and has started dosing [...]
Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi
13/12/2018
FDA grants breakthrough device designation to GuardantOMNI test used for plasma-based tumor mutational burden analysis in AstraZeneca trial Agreement covers immunotherapy and targeted therapy compounds REDWOOD CITY, [...]
Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M
13/12/2018
Press Release 13 December 2018 Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF [...]
Reminder- Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease Tomorrow
13/12/2018
For those who are unable to attend in person, a live webcast and replay will be accessible here HAIFA, Israel, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading [...]
XBiotech annonce la publication de l'analyse post-hoc pour une étude sur le cancer colorectal de Phase III
13/12/2018
Les biomarqueurs prédisent des taux de réponse au traitement au bermekimab considérablement plus élevés chez les patients atteints d'un cancer de stade avancé AUSTIN, Texas, 13 déc. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc [...]
Mariner Endosurgery Wins FDA Clearance for Groundbreaking Augmented Surgical System LaparoGuard
13/12/2018
New navigation system brings surgeons unprecedented 3D spatial awareness during minimally invasive abdominal procedures Washington, DC, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Following months of review, the US Food and Drug [...]
Sharecare launches Sharecare Rx to help make medications more affordable and convenient
13/12/2018
Sharecare expands its dynamic personal health management platform with new digital pharmacy savings card powered by CVS Caremark for generic and branded medications; adds drug safety information, motivation and support [...]
VBI Vaccines Announces Pricing of $37.5 Million Public Offering
13/12/2018
CAMBRIDGE, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]
Aptevo Therapeutics Doses First Patient in Phase 1/1b Clinical Trial of Lead Next-Generation Bispecific Antibody APVO436
13/12/2018
Preclinical Data for APVO436 Show Potential Best-in-Class Attributes with Potent T-Cell Directed Tumor Killing and Reduced Cytokine Production Compared to a Competitor Construct Phase 1/1b Clinical Trial to Evaluate [...]
Deep Blue Med Spa Announces New Profound Procedure to Treat Wrinkles and Rejuvenate Jawline
13/12/2018
LONG ISLAND, NY, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Deep Blue Med Spa, overseen by the plastic surgeons at Long Island Plastic Surgical Group , is pleased to announce the addition of Profound, a unique microneedling [...]
Symphony Health Announces Availability of 340B Drug Discount Program Data
13/12/2018
Program data provides comprehensive measurement of large-scale 340B transaction activity across outlets BLUE BELL, Pa., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Symphony Health , a PRA Health Sciences company and a leading [...]
Agritek Holdings, Inc. Applauds Passing Of 2018 US Hemp Farm Bill With Company Poised To Monetize Colorado Assets Through Approved Hemp License And Production Partners
13/12/2018
LOS ANGELES, CA, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]
Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome
13/12/2018
MENLO PARK, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) announced today that the United States Patent and Trademark Office has given notice that it will allow a patent [...]
Blockchain Technology Offers a Solution to Cannabis Quality Control -- CFN Media
13/12/2018
SEATTLE, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Yield10 Bioscience Names Sherri M. Brown, Ph.D., Former Monsanto Executive, as Special Commercial and Technical Advisor
13/12/2018
WOBURN, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, today [...]
Aleafia Health: A New LP with 22 Medical Clinics, 50K Patients and 98,000 kg Production -- CFN Media
13/12/2018
SEATTLE, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with Osteoarthritis
13/12/2018
MELBOURNE, Australia, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that the Australian [...]

Pages